相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
Anthony Traboulsee et al.
LANCET NEUROLOGY (2020)
Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial
Chao Zhang et al.
LANCET NEUROLOGY (2020)
Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica
John Soltys et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder
S. J. Pittock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Epidemiologic and Clinical Characteristics of Optic Neuritis in Japan
Hitoshi Ishikawa et al.
OPHTHALMOLOGY (2019)
Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity
Tianjiao Duan et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
Bruce A. C. Cree et al.
LANCET (2019)
Compendium of current complement therapeutics
Wioleta M. Zelek et al.
MOLECULAR IMMUNOLOGY (2019)
Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder
Takashi Yamamura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Clinical characteristics of myelin oligodendrocyte glycoprotein seropositive optic neuritis: a cohort study in Shanghai, China
Guixian Zhao et al.
JOURNAL OF NEUROLOGY (2018)
Worldwide prevalence of neuromyelitis optica spectrum disorders
Masahiro Mori et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica
Karol Estrada et al.
NATURE COMMUNICATIONS (2018)
Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic Penang Island, Malaysia, and a review of worldwide prevalence
Jyh Yung Hor et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Open-label, add-on trial of cetirizine for neuromyelitis optica
Ilana Katz Sand et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Efficiency of antibody therapy in demyelinating diseases
Tetsuya Akaishi et al.
INTERNATIONAL IMMUNOLOGY (2017)
Gender differences among Chinese patients with neuromyelitis optica spectrum disorders
Hui Sun et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: A multicenter cohort study
Remi A. Kessler et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
Distinct clinical characteristics of atypical optic neuritis with seronegative aquaporin-4 antibody among Chinese patients
Huanfen Zhou et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2017)
Demyelinating diseases in Asia
Hirofumi Ochi et al.
CURRENT OPINION IN NEUROLOGY (2016)
MEDI-551 Treatment Effectively Depletes B Cells and Reduces Serum Titers of Autoantibodies in Mice Transgenic for Sle1 and Human CD19
Sandra Gallagher et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Demographic and clinical features of neuromyelitis optica: A review
L. Pandit et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder
Marius Ringelstein et al.
JAMA NEUROLOGY (2015)
Demographic and clinical features of neuromyelitis optica: A review
L. Pandit et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Specificity and sensitivity of aquaporin 4 antibody detection tests in patients with neuromyelitis optica: A meta-analysis
Rafael Ruiz-Gaviria et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2015)
Update on biomarkers in neuromyelitis optica
Esther Melamed et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
B lymphocytes in neuromyelitis optica
Jeffrey L. Bennett et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Clinical Features and Sera Anti-Aquaporin 4 Antibody Positivity in Patients with Demyelinating Disorders of the Central Nervous System from Tianjin, China
Chun-Sheng Yang et al.
CNS NEUROSCIENCE & THERAPEUTICS (2014)
A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission
Nora Veszeli et al.
MOLECULAR IMMUNOLOGY (2014)
Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica A pilot study
Manabu Araki et al.
NEUROLOGY (2014)
Complement Is Activated by IgG Hexamers Assembled at the Cell Surface
Christoph A. Diebolder et al.
SCIENCE (2014)
Biology of AQP4 and Anti-AQP4 Antibody: Therapeutic Implications for NMO
A. S. Verkman et al.
BRAIN PATHOLOGY (2013)
Aquaporins, anti-aquaporin-4 autoantibodies and neuromyelitis optica
Concepcion Gonzalez et al.
CLINICA CHIMICA ACTA (2013)
Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks
Akiyuki Uzawa et al.
CLINICA CHIMICA ACTA (2013)
Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica
Hua Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study
Sean J. Pittock et al.
LANCET NEUROLOGY (2013)
Aquaporin-4 antibody-negative neuromyelitis optica Distinct assay sensitivity-dependent entity
Romain Marignier et al.
NEUROLOGY (2013)
Plasmablasts as Migratory IgG-Producing Cells in the Pathogenesis of Neuromyelitis Optica
Norio Chihara et al.
PLOS ONE (2013)
Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica Implication for Cellular Immune Responses
Bernd C. Kieseier et al.
JAMA NEUROLOGY (2013)
Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy
Ilya Ayzenberg et al.
JAMA NEUROLOGY (2013)
Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss
Julien Ratelade et al.
ACTA NEUROPATHOLOGICA (2012)
Anti-Aquaporin-4 Monoclonal Antibody Blocker Therapy for Neuromyelitis Optica
Lukmanee Tradtrantip et al.
ANNALS OF NEUROLOGY (2012)
Neutrophil Protease Inhibition Reduces Neuromyelitis Optica-Immunoglobulin G-Induced Damage in Mouse Brain
Samira Saadoun et al.
ANNALS OF NEUROLOGY (2012)
Complement-dependent Cytotoxicity in Neuromyelitis Optica Requires Aquaporin-4 Protein Assembly in Orthogonal Arrays
Puay-Wah Phuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Disc swelling and mild initial visual acuity loss predict a better short-term visual acuity outcome in bilateral acute optic neuritis
Yi Du et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
Sera from neuromyelitis optica patients disrupt the blood-brain barrier
Fumitaka Shimizu et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4
Woojun Kim et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence
Anu Jacob et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Notable Increased Cerebrospinal Fluid Levels of Soluble Interleukin-6 Receptors in Neuromyelitis Optica
Honghao Wang et al.
NEUROIMMUNOMODULATION (2012)
Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes
Shannon R. Hinson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms
Hua Zhang et al.
ANNALS OF NEUROLOGY (2011)
Unilateral optic neuritis in a Chinese population in three centers
Yi Du et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes
Akiko Nagaishi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Antibodies against aquaporin-4 in neuromyelitis optica: distinction between recurrent and monophasic patients
Immy A. Ketelslegers et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
A Comparison of Optic Neuritis in Asian and in Western Countries
Lin-Chung Woung et al.
NEURO-OPHTHALMOLOGY (2011)
Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
Norio Chihara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice
Samira Saadoun et al.
BRAIN (2010)
Evidences for a Leaky Scanning Mechanism for the Synthesis of the Shorter M23 Protein Isoform of Aquaporin-4 IMPLICATION IN ORTHOGONAL ARRAY FORMATION AND NEUROMYELITIS OPTICA ANTIBODY INTERACTION
Andrea Rossi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
HIGHER ORDER STRUCTURE OF AQUAPORIN-4
G. P. Nicchia et al.
NEUROSCIENCE (2010)
Intrathecal Pathogenic Anti-Aquaporin-4 Antibodies in Early Neuromyelitis Optica
Jeffrey L. Bennett et al.
ANNALS OF NEUROLOGY (2009)
Live Cell Analysis of Aquaporin-4 M1/M23 Interactions and Regulated Orthogonal Array Assembly in Glial Cells
Jonathan M. Crane et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: An in vitro study
Lidia Sabater et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
CD19: a promising B cell target for rheumatoid arthritis
Thomas F. Tedder
NATURE REVIEWS RHEUMATOLOGY (2009)
Why we should treat idiopathic optic neuritis with high-dose and long-term corticosteroids in China
Yi Du et al.
MEDICAL HYPOTHESES (2009)
A CASE OF NMO SEROPOSITIVE FOR AQUAPORIN-4 ANTIBODY MORE THAN 10 YEARS BEFORE ONSET
S. Nishiyama et al.
NEUROLOGY (2009)
The molecular composition of square Arrays
Jan Gunnar Sorbo et al.
BIOCHEMISTRY (2008)
Formation of aquaporin-4 arrays is inhibited by palmitoylation of N-terminal cysteine residues
Hiroshi Suzuki et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2008)
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
S. Jarius et al.
BRAIN (2008)
New isoforms of rat Aquaporin-4
Svein Erik Moe et al.
GENOMICS (2008)
Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment
Thierry Vincent et al.
JOURNAL OF IMMUNOLOGY (2008)
Aquaporin-4 dynamics in orthogonal Arrays in live cells visualized by quantum dot single particle tracking
Jonathan M. Crane et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
The etiology of optic neuritis in Asian population
Yi Du et al.
MEDICAL HYPOTHESES (2008)
FDA Report: Eculizumab (Soliris (R)) for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria
Andrew Dmytrijuk et al.
ONCOLOGIST (2008)
Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica
Sven Jarius et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica
S. R. Hinson et al.
NEUROLOGY (2007)
Analysis of multiple sclerosis cerebrospinal fluid reveals a continuum of clonally related antibody-secreting cells that are predominantly plasma blasts
Kimberly M. Winges et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Viral load determines the B-cell response in the cerebrospinal fluid during human immunodeficiency virus infection
Sabine Cepok et al.
ANNALS OF NEUROLOGY (2007)
Measles virus-specific plasma cells are prominent in subacute sclerosing panencephalitis CSF
G. P. Owens et al.
NEUROLOGY (2007)
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis
Shanu F. Roemer et al.
BRAIN (2007)
Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis
T. Misu et al.
BRAIN (2007)
Clinical features of optic neuritis in China
Xiaojun Zhang et al.
NEURO-OPHTHALMOLOGY (2007)
The spectrum of neuromyelitis optica
Dean M. Wingerchuk et al.
LANCET NEUROLOGY (2007)
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
VA Lennon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
More than just water channels: unexpected cellular roles of aquaporins
AS Verkman
JOURNAL OF CELL SCIENCE (2005)
Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis
S Cepok et al.
BRAIN (2005)
Membrane organization and function of M1 and M23 isoforms of aquaporin-4 in epithelial cells
C Silberstein et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
VA Lennon et al.
LANCET (2004)
Aquaporin water channels (Nobel lecture)
P Agre
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2004)
The molecular basis of water transport in the brain
M Amiry-Moghaddam et al.
NATURE REVIEWS NEUROSCIENCE (2003)
Aquaporin-4 square array assembly: Opposing actions of M1 and M23 isoforms
CS Furman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
CF Lucchinetti et al.
BRAIN (2002)
Aquaporin water channels - from atomic structure to clinical medicine
P Agre et al.
JOURNAL OF PHYSIOLOGY-LONDON (2002)
分享论文
